Neurovascular effects of CD47 signaling: Promotion of cell death, inflammation, and suppression of angiogenesis in brain endothelial cells in vitro

Journal of Neuroscience Research

Volumn 87, Issue 11, 2009, Pages 2571-2577

  Xing, Changhong ^a   Lee, Sunryung ^a,b   Woo, Jean Kim ^a   Wang, Hui ^a   Yang, Yong Guang ^a   Ning, MingMing ^a   Wang, Xiaoying ^a   Lo, Eng H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Jeju National University   (South Korea)

Author keywords

Angiogenesis; CD47; Cell death; Endothelial cell; Inflammation

Indexed keywords

CD47 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; THROMBOSPONDIN 1; VASCULAR CELL ADHESION MOLECULE 1; 4N1K PEPTIDE; CD47 PROTEIN, HUMAN; CD47 PROTEIN, MOUSE; OLIGOPEPTIDE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BRAIN CELL; BRAIN INJURY; CELL MIGRATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; ENDOTHELIUM CELL; GENE TARGETING; HUMAN; HUMAN CELL; MICROVASCULARIZATION; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; STROKE; UPREGULATION; ANIMAL; BRAIN; CELL CULTURE; CELL DEATH; CELL MOTION; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; MALE; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; ANTIGENS, CD47; BRAIN; CELL DEATH; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROIMMUNOMODULATION; OLIGOPEPTIDES; THROMBOSPONDIN 1; VASCULAR CELL ADHESION MOLECULE-1;

EID: 70349242264     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22076     Document Type: Article

References (56)

1. Abbott NJ, Ronnback L, Hansson E. 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41-53.
2. Adams JC, Lawler J. 2004. The thrombospondins. Int J Biochem Cell Biol 36:961-968.
3. Blake SM, Strasser V, Andrade N, Duit S, Hofbauer R, Schneider WJ, Nimpf J. 2008. Thrombospondin-1 binds to ApoER2 and VLDL receptor and functions in postnatal neuronal migration. EMBO J 27:3069-3080.
4. Bras M, Yuste VJ, Roue G, Barbier S, Sancho P, Virely C, Rubio M, Baudet S, Esquerda JE, Merle-Beral H, Sarfati M, Susin SA. 2007. Drp1 mediates caspase-independent type III cell death in normal and leukemic cells. Mol Cell Biol 27:7073-7088. (Pubitemid 47549746)
5. Brines M, Cerami A. 2005. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6:484-494. (Pubitemid 40769173)
6. Brown EJ, Frazier WA. 2001. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 11:130-135.
7. Callahan MK, Williams KA, Kivisakk P, Pearce D, Stins MF, Ransohoff RM. 2004. CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer. J Neuroimmunol 153:150-157. (Pubitemid 38950937)
8. Chen HH, Chien CH, Liu HM. 1994. Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct. Stroke 25:1651-1657. (Pubitemid 24233974)
9. Cooper D, Lindberg FP, Gamble JR, Brown EJ, Vadas MA. 1995. Transendothelial migration of neutrophils involves integrin-associated protein (CD47). Proc Natl Acad Sci U S A 92:3978-3982.
10. Dawson DW, Pearce SF, Zhong R, Silverstein RL, Frazier WA, Bouck NP. 1997. CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol 138:707-717. (Pubitemid 27349849)
11. Demeure CE, Tanaka H, Mateo V, Rubio M, Delespesse G, Sarfati M. 2000. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J Immunol 164:2193-2199. (Pubitemid 30108779)
12. Dewar D, Underhill SM, Goldberg MP. 2003. Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab 23:263-274.
13. Esemuede N, Lee T, Pierre-Paul D, Sumpio BE, Gahtan V. 2004. The role of thrombospondin-1 in human disease. J Surg Res 122:135-142.
14. Fisher M. 2008. Injuries to the vascular endothelium: vascular wall and endothelial dysfunction. Rev Neurol Dis 5(Suppl 1):S4-S11.
15. Gidday JM. 2006. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7:437-448.
16. Gobbel GT, Chan TY, Gregory GA, Chan PH. 1994. Response of cerebral endothelial cells to hypoxia: modification by fructose-1,6-bisphosphate but not glutamate receptor antagonists. Brain Res 653:23-30.
17. Greenberg DA, Jin K. 2005. From angiogenesis to neuropathology. Nature 438:954-959.
18. Griffin JH, Zlokovic B, Fernandez JA. 2002. Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke. Semin Hematol 39:197-205. (Pubitemid 34793041)
19. Guo S, Kim WJ, Lok J, Lee SR, Besancon E, Luo BH, Stins MF, Wang X, Dedhar S, Lo EH. 2008. Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. Proc Natl Acad Sci U S A 105:7582-7587. (Pubitemid 351830061)
20. Hagnerud S, Manna PP, Cella M, Stenberg A, Frazier WA, Colonna M, Oldenborg PA. 2006. Deficit of CD47 results in a defect of marginal zone dendritic cells, blunted immune response to particulate antigen and impairment of skin dendritic cell migration. J Immunol 176:5772-5778.
21. Iadecola C. 2004. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5:347-360. (Pubitemid 38568496)
22. Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD. 2006. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 281:26069-26080. (Pubitemid 44401813)
23. Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N. 2000. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6:41-48. (Pubitemid 30048524)
24. Jin G, Tsuji K, Xing C, Yang YG, Wang X, Lo EH. 2009. CD47 gene knockout protects against transient focal cerebral ischemia in mice. Exp Neurol (in press).
25. Johansson U, Higginbottom K, Londei M. 2004. CD47 ligation induces a rapid caspase-independent apoptosis-like cell death in human monocytes and dendritic cells. Scand J Immunol 59:40-49. (Pubitemid 38186838)
26. Koshimizu H, Araki T, Takai S, Yokomaku D, Ishikawa Y, Kubota M, Sano S, Hatanaka H, Yamada M. 2002. Expression of CD47/integrin-associated protein induces death of cultured cerebral cortical neurons. J Neurochem 82:249-257. (Pubitemid 34774616)
27. Lawler J, Detmar M. 2004. Tumor progression: the effects of thrombospondin-1 and -2. Int J Biochem Cell Biol 36:1038-1045.
28. Lazarovici P, Marcinkiewicz C, Lelkes PI. 2006. Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr Pharm Des 12:2609-2622.
29. Lee SR, Lo EH. 2003. Interactions between p38 mitogen-activated protein kinase and caspase-3 in cerebral endothelial cell death after hypoxia-reoxygenation. Stroke 34:2704-2709. (Pubitemid 37392771)
30. Lindberg FP, Bullard DC, Caver TE, Gresham HD, Beaudet AL, Brown EJ. 1996. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 274:795-798.
31. Lo EH, Dalkara T, Moskowitz MA. 2003. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4:399-415.
32. Lo EH. 2008a. A new penumbra: transitioning from injury into repair after stroke. Nat Med 14:497-500.
33. Lo EH. 2008b. Experimental models, neurovascular mechanisms and translational issues in stroke research. Br J Pharmacol 153(Suppl 1):S396-S405.
34. Lok J, Gupta P, Guo S, Kim WJ, Whalen MJ, van Leyen K, Lo EH. 2007. Cell-cell signaling in the neurovascular unit. Neurochem Res 32:2032-2045.
35. Manna PP, Frazier WA. 2003. The mechanism of CD47-dependent killing of T cells: heterotrimeric Gi-dependent inhibition of protein kinase A. J Immunol 170:3544-3553.
36. Manna PP, Frazier WA. 2004. CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A. Cancer Res 64:1026-1036.
37. Mateo V, Lagneaux L, Bron D, Biron G, Armant M, Delespesse G, Sarfati M. 1999. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nat Med 5:1277-1284. (Pubitemid 29535605)
38. Mateo V, Brown EJ, Biron G, Rubio M, Fischer A, Deist FL, Sarfati M. 2002. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization. Blood 100:2882-2890.
39. Mazzone M, Carmeliet P. 2008. Drug discovery: a lifeline for suffocating tissues. Nature 453:1194-1195. (Pubitemid 351913585)
40. Mosher DF, Misenheimer TM, Stenflo J, Hogg PJ. 1992. Modulation of fibrinolysis by thrombospondin. Ann N Y Acad Sci 667:64-69.
41. Narizhneva NV, Razorenova OV, Podrez EA, Chen J, Chandrasekharan UM, DiCorleto PE, Plow EF, Topol EJ, Byzova TV. 2005. Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. FASEB J 19:1158-1160. (Pubitemid 40946450)
42. Oganesian A, Armstrong LC, Migliorini MM, Strickland DK, Bornstein P. 2008. Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells. Mol Biol Cell 19:563-571. (Pubitemid 351272145)
43. Ohab JJ, Fleming S, Blesch A, Carmichael ST. 2006. A neurovascular niche for neurogenesis after stroke. J Neurosci 26:13007-13016.
44. Parent JM. 2003. Injury-induced neurogenesis in the adult mammalian brain. Neuroscientist 9:261-272. (Pubitemid 36899114)
45. Plateel M, Dehouck MP, Torpier G, Cecchelli R, Teissier E. 1995. Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer. J Neurochem 65:2138-2145.
46. Rossi DJ, Brady JD, Mohr C. 2007. Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci 10:1377-1386. (Pubitemid 350014689)
47. Saumet A, Slimane MB, Lanotte M, Lawler J, Dubernard V. 2005. Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/alphavbeta3 in promyelocytic leukemia NB4 cells. Blood 106:658-667. (Pubitemid 40981264)
48. Slevin M, Kumar P, Gaffney J, Kumar S, Krupinski J. 2006. Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin Sci (Lond) 111:171-183. (Pubitemid 44352189)
49. Thiyagarajan M, Fernandez JA, Lane SM, Griffin JH, Zlokovic BV. 2008. Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1. J Neurosci 28:12788-12797.
50. Thored P, Wood J, Arvidsson A, Cammenga J, Kokaia Z, Lindvall O. 2007. Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke 38:3032-3039. (Pubitemid 350035699)
51. Xing C, Lee S, Kim WJ, Jin G, Yang YG, Ji X, Wang X, Lo EH. 2009. Role of oxidative stress and caspase 3 in CD47-mediated neuronal cell death. J Neurochem 108:430-436.
52. Yenari M, Kitagawa K, Lyden P, Perez-Pinzon M. 2008. Metabolic downregulation: a key to successful neuroprotection? Stroke 39:2910-2917.
53. Yong VW, Wells J, Giuliani F, Casha S, Power C, Metz LM. 2004. The promise of minocycline in neurology. Lancet Neurol 3:744-751.
54. Zhang Y, Zhang X, Park TS, Gidday JM. 2005. Cerebral endothelial cell apoptosis after ischemia-reperfusion: role of PARP activation and AIF translocation. J Cereb Blood Flow Metab 25:868-877. (Pubitemid 40905614)
55. Zlokovic BV. 2005. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28:202-208.
56. Zlokovic BV. 2008. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178-201.